Spero Therapeutics, Inc. Accumulated Other Comprehensive Income
Spero Therapeutics, Inc. (SPRO) had Accumulated Other Comprehensive Income of $0 as of 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-03-13
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-13 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-13 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$6.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$2.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$2.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$2.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$3.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$7.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $15.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$19.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $16.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $18.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $6.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$28.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | -$23.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$15.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$29.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |